Phase Forward Signs Multi-Year Agreement with Major Pharmaceutical Company Gedeon Richter
Waltham, MA
Phase Forward announced a multi-year agreement with Gedeon Richter Plc., a leading pharmaceutical company in Central-Eastern Europe. Gedeon Richter plans to adopt Phase Forward’s Clintrial™ product for its clinical trial data management activities.
Founded in 1901 and headquartered in Budapest, Hungary, Gedeon Richter’s organization manufactures and markets generic pharmaceutical products for the treatment of a variety of therapy areas including gynecology and cardiology. After completing a competitive product review, Gedeon Richter selected Phase Forward.
“We know that we are collaborating with the premier technology provider for clinical trials – and we look forward to garnering the benefits inherent in greater drug trial efficiencies,” said György Németh, medical director, Gedeon Richter.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
